Drugs / Peginterferon-α2a
Peginterferon-α2a
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02175966 | Jul 2014 → Jan 2015 | hepatitis C virus infection | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 2 | NCT01463956 | Jan 2012 → Jun 2014 | chronic hepatitis C virus infection, cirrhosis of liver | French National Agency for Research on AIDS and Viral Hepatitis | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01277601 | Apr 2011 → Aug 2014 | chronic hepatitis B virus infection | Gilead Sciences | Completed | No outcome recorded |
| Phase 4 | NCT00881582 | Jan 2009 → Dec 2011 | chronic hepatitis C virus infection | King Abdulaziz Medical City | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02381379 Comparator | Mar 2015 → Oct 2018 | chronic myeloid leukemia | Ministry of Health, Malaysia | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peginterferon-α2a | “Patients chronically infected with the hepatitis B virus rarely achieve loss of serum hepatitis B surface antigen (HBsAg) with the standard of care. We evaluated HBsAg loss in...” PMID 26453773 ↗ Oct 20154“Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C.” PMID 23428875 ↗ Feb 2013 |
| Known as | PEG-interferon alfa-2a | “PEG-interferon alfa-2a and ribavirin.” NCT00881582 ↗ |
| Known as | PegIFNα-2a | “We assessed the safety and efficacy of PegIFNα-2a and ribavirin (RBV) combination therapy in HCV-infected RT recipients.” PMID 23428875 ↗ Feb 2013 |
| Known as | Pegylated interferon alfa-2a | “Pegylated interferon alfa-2a - standard dose; plus ribavirin - standard dose” NCT00881582 ↗ |
| Route | Subcutaneous | “Peg-IFN 180 µg administered via subcutaneous injection once weekly” NCT01277601 ↗ |